Lemonade (LMND) Gets a Hold from Morgan Stanley
Morgan Stanley analyst Bob Huang maintained a Hold rating on Lemonade (LMND – Research Report) today and set a price target of $34.00. The ...
Investing4d
23andMe considers selling its telehealth unit Lemonaid
Investing.com -- Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to Business Insider. The company, which has faced financial ...
23andMe exploring possible sale of telehealth business, BI reports
Me (ME) has been quietly exploring a possible sale of its telehealth business, Lemonaid, according to Business Insider.Stay Ahead of the ...
23andMe has been quietly exploring a possible sale of its telehealth business, Lemonaid
Struggling genetic testing 23andMe is looking for a buyer for the virtual care business it acquired in 2021, Business Insider ...